Company intelligence / Profile preview

Youfeng

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Youfeng Bio is a clinical-stage biopharmaceutical company based in Suzhou, China, focused on the discovery and development of innovative small molecule therapeutics. The company primarily targets metabolic diseases, oncology, and autoimmune disorders through its proprietary drug discovery engine. Its lead candidate, YF-001, is a potent URAT1 inhibitor currently in Phase 2 clinical trials for the treatment of gout and hyperuricemia. Additionally, Youfeng Bio is advancing a pipeline of immune-modulating agents, including TLR7/8 agonists for cancer immunotherapy and TYK2 inhibitors for inflammatory conditions.

Therapeutic areas: Metabolic DisordersDermatologyImmunologyRheumatologyOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Youfeng.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Youfeng.

Explore the full profile